Potential adverse effects of SGLT2i in horses.
Abstract: No abstract available
Publication Date: 2024-11-01 PubMed ID: 39485213DOI: 10.1002/vetr.4726Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
- Letter
Cite This Article
APA
McGorum BC, Keen JA, McCullagh S, Marr CM, MacKenzie C, Carslake H, Menzies-Gow N, Dunkel B, Hewetson M, Reed J, Knowles E.
(2024).
Potential adverse effects of SGLT2i in horses.
Vet Rec, 195(6), 253-254.
https://doi.org/10.1002/vetr.4726 Publication
Researcher Affiliations
- Royal (Dick) School of Veterinary Studies, Roslin, Midlothian, EH25 9RG.
- Royal (Dick) School of Veterinary Studies, Roslin, Midlothian, EH25 9RG.
- Royal (Dick) School of Veterinary Studies, Roslin, Midlothian, EH25 9RG.
- Rossdales Equine Hospital, Cotton End Road, Exning, Newmarket, CB8 7NN.
- Rossdales Equine Hospital, Cotton End Road, Exning, Newmarket, CB8 7NN.
- Leahurst Equine Hospital, University of Liverpool, Neston, Cheshire, CH64 7TE.
- Royal Veterinary College, Hawkshead Lane, Hatfield, AL9 7TA.
- Royal Veterinary College, Hawkshead Lane, Hatfield, AL9 7TA.
- Royal Veterinary College, Hawkshead Lane, Hatfield, AL9 7TA.
- Royal Veterinary College, Hawkshead Lane, Hatfield, AL9 7TA.
- Royal Veterinary College, Hawkshead Lane, Hatfield, AL9 7TA.
References
This article includes 7 references
- Kellon EM, Gustafson KM. Hypertriglyceridemia in equines with refractory hyperinsulinemia treated with SGLT2 inhibitors. Open Vet J 2023;13:365–75.
- Kellon EM, Gustafson KM. Use of the SGLT2 inhibitor canagliflozin for control of refractory equine hyperinsulinemia and laminitis. Open Vet J 2022;12:511–8.
- Sundra T, Kelty E, Rendle D. Preliminary observations on the use of ertugliflozin in the management of hyperinsulinaemia and laminitis in 51 horses: a case series. Equine Vet Educ 2022;35:311–20.
- Sundra T, Lester G, Rossi G. Sodium-glucose cotransporter 2 inhibitors in horses – magic bullet or latest fad?. Equine Vet J 2023;55:559–62.
- Meier A, Reiche D, de Laat M. The sodium-glucose co-transporter 2 inhibitor velagliflozin reduces hyperinsulinemia and prevents laminitis in insulin-dysregulated ponies. PLoS ONE 2018;13:e0203655.
- Menzies-Gow NJ, Knowles EJ. Sodium-glucose transport protein 2 inhibitor use in the management of insulin dysregulation in ponies and horses. J Vet Pharmacol Ther 2024.
- Sundra T, Rossi G, Lester G. Horse owner experiences and observations with the use of SGLT2i for the management of equine metabolic syndrome and hyperinsulinaemia-associated laminitis. Equine Vet Educ 2024.
Citations
This article has been cited 0 times.Use Nutrition Calculator
Check if your horse's diet meets their nutrition requirements with our easy-to-use tool Check your horse's diet with our easy-to-use tool
Talk to a Nutritionist
Discuss your horse's feeding plan with our experts over a free phone consultation Discuss your horse's diet over a phone consultation
Submit Diet Evaluation
Get a customized feeding plan for your horse formulated by our equine nutritionists Get a custom feeding plan formulated by our nutritionists
